Kuldeep S. Attri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kuldeep S. Attri has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Divya Murthy
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA
21 shared publications - Pankaj K. Singh
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA
21 shared publications - Ravi Thakur
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA
21 shared publications - Ryan J. King
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA
20 shared publications - Chunbo He
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA
18 shared publications - Camila G. Pacheco
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska
17 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (9) , 1975
Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
- 4 August 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (9) , 1975
Open AccessAuthor Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
- Open Access
- 19 April 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (5) , 840
Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
- 19 April 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (5) , 840
Open AccessAuthor Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
- Open Access
- 28 March 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (14)
The MUC1–HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling
Dysregulation of polyamine metabolism has been implicated in cancer initiation and progression; however, the mechanism of polyamine dysregulation in cancer is not fully understood. In this study, we investigated the role of MUC1, a mucin protein overexpressed in pancreatic cancer, in regulating polyamine metabolism. Utilizing pancreatic cancer patient data, we noted a positive correlation between MUC1 expression and the expression of key polyamine metabolism pathway genes. Functional studies revealed that knockdown of spermidine/spermine N1-acetyltransferase 1 ( SAT1 ), a key enzyme involved in polyamine catabolism, attenuated the oncogenic functions of MUC1, including cell survival and proliferation. We further identified a regulatory axis whereby MUC1 stabilized hypoxia-inducible factor (HIF-1α), leading to increased SAT1 expression, which in turn induced carbon flux into the tricarboxylic acid cycle. MUC1-mediated stabilization of HIF-1α enhanced the promoter occupancy of the latter on SAT1 promoter and corresponding transcriptional activation of SAT1 , which could be abrogated by pharmacological inhibition of HIF-1α or CRISPR/Cas9-mediated knockout of HIF1A . MUC1 knockdown caused a significant reduction in the levels of SAT1-generated metabolites, N1-acetylspermidine and N8-acetylspermidine. Given the known role of MUC1 in therapy resistance, we also investigated whether inhibiting SAT1 would enhance the efficacy of FOLFIRINOX chemotherapy. By utilizing organoid and orthotopic pancreatic cancer mouse models, we observed that targeting SAT1 with pentamidine improved the efficacy of FOLFIRINOX, suggesting that the combination may represent a promising therapeutic strategy against pancreatic cancer. This study provides insights into the interplay between MUC1 and polyamine metabolism, offering potential avenues for the development of treatments against pancreatic cancer.
- 28 March 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (14)
Open AccessThe MUC1–HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling
Dysregulation of polyamine metabolism has been implicated in cancer initiation and progression; however, the mechanism of polyamine dysregulation in cancer is not fully understood. In this study, we investigated the role of MUC1, a mucin protein overexpressed in pancreatic cancer, in regulating polyamine metabolism. Utilizing pancreatic cancer patient data, we noted a positive correlation between MUC1 expression and the expression of key polyamine metabolism pathway genes. Functional studies revealed that knockdown of spermidine/spermine N1-acetyltransferase 1 ( SAT1 ), a key enzyme involved in polyamine catabolism, attenuated the oncogenic functions of MUC1, including cell survival and proliferation. We further identified a regulatory axis whereby MUC1 stabilized hypoxia-inducible factor (HIF-1α), leading to increased SAT1 expression, which in turn induced carbon flux into the tricarboxylic acid cycle. MUC1-mediated stabilization of HIF-1α enhanced the promoter occupancy of the latter on SAT1 promoter and corresponding transcriptional activation of SAT1 , which could be abrogated by pharmacological inhibition of HIF-1α or CRISPR/Cas9-mediated knockout of HIF1A . MUC1 knockdown caused a significant reduction in the levels of SAT1-generated metabolites, N1-acetylspermidine and N8-acetylspermidine. Given the known role of MUC1 in therapy resistance, we also investigated whether inhibiting SAT1 would enhance the efficacy of FOLFIRINOX chemotherapy. By utilizing organoid and orthotopic pancreatic cancer mouse models, we observed that targeting SAT1 with pentamidine improved the efficacy of FOLFIRINOX, suggesting that the combination may represent a promising therapeutic strategy against pancreatic cancer. This study provides insights into the interplay between MUC1 and polyamine metabolism, offering potential avenues for the development of treatments against pancreatic cancer.
- Top Cited PapersOpen Access
- 1 March 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (4) , 613-627
Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
The ability of tumour cells to thrive in harsh microenvironments depends on the utilization of nutrients available in the milieu. Here we show that pancreatic cancer-associated fibroblasts (CAFs) regulate tumour cell metabolism through the secretion of acetate, which can be blocked by silencing ATP citrate lyase (ACLY) in CAFs. We further show that acetyl-CoA synthetase short-chain family member 2 (ACSS2) channels the exogenous acetate to regulate the dynamic cancer epigenome and transcriptome, thereby facilitating cancer cell survival in an acidic microenvironment. Comparative H3K27ac ChIP–seq and RNA–seq analyses revealed alterations in polyamine homeostasis through regulation of SAT1 gene expression and enrichment of the SP1-responsive signature. We identified acetate/ACSS2-mediated acetylation of SP1 at the lysine 19 residue that increased SP1 protein stability and transcriptional activity. Genetic or pharmacologic inhibition of the ACSS2–SP1–SAT1 axis diminished the tumour burden in mouse models. These results reveal that the metabolic flexibility imparted by the stroma-derived acetate enabled cancer cell survival under acidosis via the ACSS2–SP1–SAT1 axis.
- 1 March 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (4) , 613-627
Top Cited PapersOpen AccessCancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
The ability of tumour cells to thrive in harsh microenvironments depends on the utilization of nutrients available in the milieu. Here we show that pancreatic cancer-associated fibroblasts (CAFs) regulate tumour cell metabolism through the secretion of acetate, which can be blocked by silencing ATP citrate lyase (ACLY) in CAFs. We further show that acetyl-CoA synthetase short-chain family member 2 (ACSS2) channels the exogenous acetate to regulate the dynamic cancer epigenome and transcriptome, thereby facilitating cancer cell survival in an acidic microenvironment. Comparative H3K27ac ChIP–seq and RNA–seq analyses revealed alterations in polyamine homeostasis through regulation of SAT1 gene expression and enrichment of the SP1-responsive signature. We identified acetate/ACSS2-mediated acetylation of SP1 at the lysine 19 residue that increased SP1 protein stability and transcriptional activity. Genetic or pharmacologic inhibition of the ACSS2–SP1–SAT1 axis diminished the tumour burden in mouse models. These results reveal that the metabolic flexibility imparted by the stroma-derived acetate enabled cancer cell survival under acidosis via the ACSS2–SP1–SAT1 axis.
- 17 February 2024
- Published by Elsevier in Cancer Letters
- Vol. 587, 216724
CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-κB-driven fatty acid β-oxidation in triple-negative breast cancer
- 17 February 2024
- Published by Elsevier in Cancer Letters
- Vol. 587, 216724
CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-κB-driven fatty acid β-oxidation in triple-negative breast cancer
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 7 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S7 shows that VB6 supplementation in combination with IDO and One carbon metabolism inhibition attenuates tumor burden in PDAC mice.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 7 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S7 shows that VB6 supplementation in combination with IDO and One carbon metabolism inhibition attenuates tumor burden in PDAC mice.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 1 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S1 shows that PDAC cellsregulate NK cell function by altering vitamin B6 and Tryptophan metabolism.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 1 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S1 shows that PDAC cellsregulate NK cell function by altering vitamin B6 and Tryptophan metabolism.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 7 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S7 shows that VB6 supplementation in combination with IDO and One carbon metabolism inhibition attenuates tumor burden in PDAC mice.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 7 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S7 shows that VB6 supplementation in combination with IDO and One carbon metabolism inhibition attenuates tumor burden in PDAC mice.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 4 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S4 shows that inhibition of glycogenolysis blocks VB6-mediated increased NKs effector function.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 4 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S4 shows that inhibition of glycogenolysis blocks VB6-mediated increased NKs effector function.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 5 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S5 shows that VB6 regulates the mobilization of glycogen to promote glycolysis in NK cells upon acute stimulation with target cells.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 5 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S5 shows that VB6 regulates the mobilization of glycogen to promote glycolysis in NK cells upon acute stimulation with target cells.